Synbiotic therapy (Bifidobacterium longum/Synergy 1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples